$GLYC GLYCOMIMETICS INC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GLYCOMIMETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GLYCOMIMETICS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in GLYCOMIMETICS INC for free.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: GLYC
Company Address: 9708 MEDICAL CENTER DRIVE ROCKVILLE 20850
Phone number: 240-243-1201
Market Capitalization: $140.70M
Prev close: $6.26
Average Daily Volume: 43,500
Days Low: $5.83
Year Low: $3.70
Year High: $9.25
GLYCOMIMETICS INC Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27 2021 | GLYC | GLYCOMIMETICS INC | Andrews Patricia S | Director | Option Exercise | A | 2.55 | 10,500 | 26,775 | 10,500 | |
| May 27 2021 | GLYC | GLYCOMIMETICS INC | Andrews Patricia S | Director | Grant | A | 0.00 | 5,250 | 0 | 5,250 | 0 to 5.3 K |
| May 27 2021 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 2.55 | 10,500 | 26,775 | 10,500 | |
| May 27 2021 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Grant | A | 0.00 | 5,250 | 0 | 5,250 | 0 to 5.3 K |
| Jan 22 2021 | GLYC | GLYCOMIMETICS INC | Girard Armand | SVP, Chief Business ... | Option Exercise | A | 3.81 | 50,000 | 190,500 | 50,000 | |
| Jan 22 2021 | GLYC | GLYCOMIMETICS INC | Girard Armand | SVP, Chief Business ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Jan 22 2021 | GLYC | GLYCOMIMETICS INC | Hahn Brian M. | SVP Finance, CFO | Option Exercise | A | 3.81 | 69,000 | 262,890 | 69,000 | |
| Jan 22 2021 | GLYC | GLYCOMIMETICS INC | Hahn Brian M. | SVP Finance, CFO | Grant | A | 0.00 | 34,500 | 0 | 39,760 | 5.3 K to 39.8 K (+655.89 %) |
| Jan 22 2021 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Develo ... | Option Exercise | A | 3.81 | 69,000 | 262,890 | 69,000 | |
| Jan 22 2021 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Develo ... | Grant | A | 0.00 | 34,500 | 0 | 183,115 | 148.6 K to 183.1 K (+23.21 %) |
| Jan 22 2021 | GLYC | GLYCOMIMETICS INC | Magnani John L. | SVP of Research, CS ... | Option Exercise | A | 3.81 | 69,000 | 262,890 | 69,000 | |
| Jan 22 2021 | GLYC | GLYCOMIMETICS INC | Magnani John L. | SVP of Research, CS ... | Grant | A | 0.00 | 34,500 | 0 | 324,260 | 289.8 K to 324.3 K (+11.91 %) |
| Jan 22 2021 | GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Option Exercise | A | 3.81 | 192,500 | 733,425 | 192,500 | |
| Jan 22 2021 | GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Grant | A | 0.00 | 96,250 | 0 | 452,314 | 356.1 K to 452.3 K (+27.03 %) |
| Dec 30 2020 | GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Option Exercise | M | 1.12 | 130,821 | 146,520 | 0 |